Cargando…
Effects of dexamethasone treatment on serous retinal detachment in ranibizumab-resistant diabetic macular edema
PURPOSE: To evaluate outcome of intravitreal dexamethasone implant (IDI) treatment on serous retinal detachment (SRD) in patients with ranibizumab-resistant diabetic macular edema (DME). MATERIALS AND METHODS: Forty-eight eyes of 48 patients with DME resistant to ranibizumab were enrolled in this re...
Autores principales: | Bayat, Alper Halil, Elçioğlu, Mustafa Nuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658505/ https://www.ncbi.nlm.nih.gov/pubmed/33225213 http://dx.doi.org/10.1177/2515841420971936 |
Ejemplares similares
-
A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Bayat, Alper Halil, et al.
Publicado: (2019) -
Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment
por: Kaya, Mahmut, et al.
Publicado: (2018) -
Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021) -
Characteristics of diabetic macular edema patients with serous retinal detachment
por: Hwang, Hyung Bin, et al.
Publicado: (2019) -
The corneal effects of intravitreal dexamethasone implantation
por: Bayat, Alper Halil, et al.
Publicado: (2020)